Ledger.Open graph →
SEC Form D · filed February 4, 2022

MindImmune Therapeutics, Inc

Offering
$8.9M
Sold
$5.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
KINGSTON, RI
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Stevin Zorn · Kingston, RIExec · DirectorChristopher O'Donnell · Kingston, RIDirectorRobert B. Nelson · Kingston, RIExecFarah K. Rehman · Houston, TXExec · DirectorAnthony Micali · New York, NYExecRecurring Capital, LLC · Austin, TXDirectorTracy Saxton · Bernardsville, NJDirectorDiane Gooding · Kingston, RIExecEric D. Tobias · Indianapolis, INExecMike D. Fitzgerald · Indianapolis, INExec · DirectorBruce Lyman · McLean, VADirectorTracy Saxton · San Francisco, CADirectorDiane Gooding · Kingston, RIExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗